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The past decade witnessed a few biomarkers discovered and 
validated; however, biomarker research as a whole has not 
been fruitful as expected. A majority of our efforts has been 
focused on blood, the dynamic tissue directly connecting 
every part of the body. Nevertheless, despite all the interest 
and endeavor spent on it, the blood has failed to deliver suf-
ficient number of clinically valuable biomarkers. Is it possi-
ble that we have been barking up the wrong tree? 
All cells in the body rely on a homeostatic microenvi-
ronment to survive and function. Blood, as the key provider 
of this internal environment for all tissues and organs, is 
naturally responsible to remain stable and balanced so as to 
protect organs from exposing to disturbing factors. In con-
trast, as a filtrate of the blood, urine bears no need or 
mechanism to be stable. Any change that is introduced into 
the blood either internally or externally tends to be cleared 
by the liver, kidney and/or other organs via a variety of 
mechanisms in order to maintain the homeostasis of the 
blood. In contrast, urine is the place that most of the wastes 
in blood are dumped into, and thus tolerates changes to a 
much higher degree. Biomarkers are the measurable chang-
es associated with a physiological or pathophysiological 
process. Therefore, they are more likely to be magnified and 
detectable in urine than their counterparts in blood. 
Despite the advantage of urine as a better biomarker 
source, urine biomarker research can be intimidated by the 
fact that changes in urine are much too complicated to sort 
out factors associated with any particular pathophysiologi-
cal condition, especially in human samples. Besides the 
disease to be studied, many factors may also contribute to 
the overall changes and interfere with data analysis. The 
higher the complex level of these interfering factors, the 
larger number of samples is needed in a study, which poses 
a great challenge in the research involving human objects. 
Nevertheless, due to the non-invasive nature of urine sam-
ple collection, as well as minimal technical and ethical is-
sues involved in the procedures, urine is among the most 
easily accessible biological samples ever collected from 
patients or healthy volunteers. Long-term storage and ar-
chiving of urine samples can be achieved by adsorbing uri-
nary proteins on a piece of membrane and storing them dry 
in a vacuum pouch. This simple, economical, and scalable 
approach enables comprehensive and systematic collection 
of biological samples from all patients, potentially as part of 
their medical records. With these samples available along 
with their corresponding clinical information, it will be 
much easier to conduct large-scale biomarker research and 
population-wide validations, which in turn will lead to gen-
eration of high-quality biomarkers. 
Because of the close relationship between urine and the 
urinary system, I speculate that the first group of urinary 
biomarkers established is likely to be in the nephrology 
field.  
Medical record documentation dramatically changed the 
medical practice and clinical research in the last century as 
it had laid the foundation for analyzing various medical 
cases on both individual and population levels. It is fairly 
reasonable to speculate that prospective collection and 
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storage of urinary proteins will be valuable in dis-
ease-associated biomarker discovery and assessment by 
providing the resource for decoding the biological infor-
mation stored in urine retrospectively. With the analytical 
technologies developing at an unprecedented speed, studies 
on the stored samples will presumably be more productive, 
cost-effective, and faster in the near future. The more re-
searchers and clinicians involved in digging this goldmine 
of biomarkers, the faster we will see advances in the field of 
personalized medicine in this century. 
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